Subscribe to
this category


A total of 91 posts are filed under Deals
Arena Scores $800 Million Upfront in Deal with United Therapeutics for PAH Drug
Rare Daily Staff Arena Pharmaceuticals entered into a global license agreement with United Therapeutics for Arena’s late-stage… Continue Reading
BridgeBio Enters Collaboration with Cincinnati Children’s
Rare Daily Staff BridgeBio Pharma and Cincinnati Children’s Hospital Medical Center said they are entering into a research collaboration… Continue Reading
Novo Nordisk Acquires U.S. and Canadian Rights to Strongbridge Biopharma’s Oral Diagnostic for AGHD
Rare Daily Staff Strongbridge Biopharma, a company focused on the development and commercialization of therapies for rare diseases, has… Continue Reading
AbbVie Takes Control of Cystic Fibrosis Research Program
Rare Daily Staff AbbVie said it will assume full development and commercial responsibility for its collaboration with Galapagos to discover… Continue Reading
Alexion and Dicerna Collaborate on RNAi Therapies for Complement-Mediated Diseases
Rare Daily Staff Alexion Pharmaceuticals and Dicerna Pharmaceuticals entered into a collaboration to discover and develop RNA interference… Continue Reading
CANBridge and WuXi Enter Strategic Partnership to Commercialize Rare Disease Therapies in China
Rare Daily Staff CANbridge Pharmaceutical and WuXi Biologics said they entered into a strategic partnership to enable CANbridge to develop… Continue Reading
Ionis Enters Collaboration with Roche Worth up to $760 Million
Rare Daily Staff Ionis Pharmaceuticals said it entered into a collaboration with Roche to develop IONIS-FB-LRx for the treatment of… Continue Reading

Follow us on Twitter